While all literature works consistently demonstrated that CCL20 up-regulation in invasive carcinoma, leading to a poor prognosis, the reasons behind its occurrence in dysplasia, particularly in association with NPDy, remain unknown. The gene discussed is CCL20; the disease is dysplasia.